AudioEye (AEYE) 10-K 30 Mar 17 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 30, 2017	Jun. 30, 2016
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Entity Registrant Name	AUDIOEYE INC
Entity Central Index Key	1,362,190
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 8,551,581
Trading Symbol	AEYE
Entity Common Stock, Shares Outstanding		111,994,142

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 1,409,418	$ 1,687,257
Accounts receivable, net	44,645	22,741
Marketable securities, held in related party	1,200	3,600
Non-marketable securities, held in related party	0	50,000
Prepaid expenses and other current assets	19,560	41,388
Total current assets	1,474,823	1,804,986
Intangible assets, net	2,313,249	2,840,856
Goodwill	700,528	700,528
Total assets	4,488,600	5,346,370
Current liabilities:
Accounts payable and accrued expenses	245,677	213,620
Notes and loans payable, current	23,800	24,000
Related party payables	32,118	153,474
Derivative liabilities	3,478,626	439,361
Deferred rent	207	0
Deferred revenue	386,485	60,790
Total current liabilities	4,166,913	891,245
Long term liabilities:
Deferred rent	14,450	0
Convertible notes,-related party net	0	1,365,684
Convertible notes and loans payable, net	0	557,815
Total liabilities	4,181,363	2,814,744
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, 160,000 and 175,000 issued and outstanding as of December 31, 2016 and 2015, respectively	2	2
Common stock, $0.00001 par value, 250,000,000 shares authorized, 111,512,001 and 81,717,154 shares issued and outstanding as of December 31, 2016 and 2015, respectively	1,115	817
Additional paid in capital	34,124,181	26,770,238
Accumulated deficit	(33,818,061)	(24,239,431)
Total stockholders' equity	307,237	2,531,626
Total liabilities and stockholders' equity	$ 4,488,600	$ 5,346,370

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Preferred Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	160,000	175,000
Preferred Stock, Shares Outstanding	160,000	175,000
Common Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	111,512,001	81,717,154
Common Stock, Shares, Outstanding	111,512,001	81,717,154

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues	$ 994,265	$ 338,863
Cost of revenue	1,226,321	1,224,652
Gross Loss	(232,056)	(885,789)
Operating expenses:
Selling and marketing	713,972	884,440
Research and development	343,712	375,817
General and administrative	2,568,227	4,633,702
Impairment of related party non-marketable securities	50,000	0
Amortization and depreciation	570,247	534,220
Total operating expenses	4,246,158	6,428,179
Operating loss	(4,478,214)	(7,313,968)
Other income (expense):
Unrealized gain (loss) on derivative liabilities	(2,758,488)	187,932
Unrealized loss on marketable securities	(2,400)	(10,200)
Loss on settlement of debt	(1,664,281)	0
Other income	750	3,814
Interest expense	(675,997)	(76,723)
Total other income (expense)	(5,100,416)	104,823
Net loss	(9,578,630)	(7,209,145)
Deemed dividend on Series A Convertible preferred stock	0	(594,641)
Dividend on Series A Convertible preferred stock	(80,000)	(58,733)
Net loss available to common stockholders	$ (9,658,630)	$ (7,862,519)
Net loss per common share-basic and diluted	$ (0.10)	$ (0.10)
Weighted average common shares outstanding-basic and diluted	98,905,556	80,445,509

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2014	$ 5,863,955	$ 778	$ 0	$ 22,893,463	$ (17,030,286)
Balance (in shares) at Dec. 31, 2014		77,817,861	0
Preferred stock issued for cash	1,750,000	$ 0	$ 2	1,749,998	0
Preferred stock issued for cash (in shares)		0	175,000
Common stock issued for cash and subscription receivables, net	325,000	$ 8	$ 0	324,992	0
Common stock issued for cash and subscription receivables, net (in shares)		812,500	0
Common stock issued for exercise of warrants	43,941	$ 1	$ 0	43,940	0
Common stock issued for exercise of warrants (in shares)		109,855	0
Common stock issued for services	682,126	$ 31	$ 0	682,095	0
Common stock issued for services (in shares)		3,101,936	0
Warrants issued for cancellation of common stock	0	$ (1)	$ 0	1	0
Warrants issued for cancellation of common stock (in shares)		(124,998)	0
Warrants, Options, PSU issued for services	1,075,749	$ 0	$ 0	1,075,749	0
Net loss	(7,209,145)	0	0	0	(7,209,145)
Balance at Dec. 31, 2015	2,531,626	$ 817	$ 2	26,770,238	(24,239,431)
Balance (in shares) at Dec. 31, 2015		81,717,154	175,000
Common stock issued for services	63,292	$ 5	$ 0	63,287	0
Common stock issued for services (in shares)		416,664	0
Common stock issued in settlement of convertible notes and accrued interest	1,078,123	$ 128	$ 0	1,077,995	0
Common stock issued in settlement of convertible notes and accrued interest (in shares)		12,834,800	0
Common stock issued for cash, net of placement costs of $60,918	2,129,082	$ 156	$ 0	2,128,926	0
Common stock issued for cash, net of placement costs of $60,918 (in shares)		15,642,858	0
Common stock issued upon conversion of preferred stock	0	$ 9	$ 0	(9)	0
Common stock issued upon conversion of preferred stock (in shares)		900,525	(15,000)
Fair value of warrants issued in settlement of convertible debt and accrued interest	3,205,959	$ 0	$ 0	3,205,959	0
Reclassify fair value of liability warrants issued in connection with sale of common stock	(280,777)	0	0	(280,777)	0
Warrants and Options issued for services	1,085,645	0	0	1,085,645	0
Restricted stock units issued in payment of accrued compensation	72,917	0	0	72,917	0
Net loss	(9,578,630)	0	0	0	(9,578,630)
Balance at Dec. 31, 2016	$ 307,237	$ 1,115	$ 2	$ 34,124,181	$ (33,818,061)
Balance (in shares) at Dec. 31, 2016		111,512,001	160,000

CONSOLIDATED STATEMENT OF STOC6

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical)	12 Months Ended
	Dec. 31, 2016USD ($)
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 60,918

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss)	$ (9,578,630)	$ (7,209,145)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	570,247	534,220
Amortization of debt discounts	600,301	26,992
Option, warrant, RSU and PSU expense	1,085,645	1,075,749
Stock issued or issuable for services	63,292	682,126
Unrealized loss on marketable securities	2,400	10,200
Impairment loss on non-marketable securities	50,000	0
(Loss) gain on change in derivative liabilities	2,758,488	(187,932)
Loss on settlement of debt	1,664,281	0
Changes in operating assets and liabilities:
Accounts receivable	(21,904)	238,935
Related party receivable	0	10,000
Other current assets	21,828	49,300
Accounts payable and accruals	151,858	(566,272)
Billing in excess of costs	0	(123,908)
Deferred rent	14,657	0
Deferred revenue	325,695	60,790
Related party payables	(48,439)	(75,509)
Net cash (used in) operating activities	(2,340,281)	(5,474,454)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash (paid for) intellectual property	(42,640)	(43,689)
Software development costs	0	(233,442)
Net cash (used in) investing activities	(42,640)	(277,131)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock and warrants for cash	2,129,082	325,000
Collection of stock subscription receivable	0	1,175,000
Issuance of preferred stock for cash	0	1,750,000
Proceeds from issuance of convertible debt of which $1,775,000 related party	0	2,500,000
Proceeds from exercise of options and warrants	0	43,941
Repayments of notes payable	(24,000)	(28,000)
Net cash provided by financing activities	2,105,082	5,765,941
Net (decrease) increase in cash	(277,839)	14,356
Cash-beginning of period	1,687,257	1,672,901
Cash-end of period	1,409,418	1,687,257
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	0	4,567
Income taxes paid	0	0
Non cash investing and financing activities:
Debt discount for warrants issued with debt	0	627,293
Warrant issued for cancellation of common stock	0	1
Deemed dividend beneficial conversion feature on convertible preferred stock	0	594,641
Common stock issued in settlement of convertible notes payable and accrued interest	1,078,123	0
Fair value of warrants issued in settlement of convertible notes payable and accrued interest	3,205,959	0
Reclassify fair value of liability warrants from equity to liability upon issuance	280,777	$ 0
Restricted stock units issued in payment of accrued compensation	72,917
Common stock issued upon conversion of preferred stock	$ 9

CONSOLIDATED STATEMENTS OF CAS8

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	12 Months Ended
	Dec. 31, 2016USD ($)
Proceeds from Related Party Debt	$ 1,775,000

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 — ORGANIZATION AudioEye, Inc. (the “Company”) was incorporated on May 20, 2005 in the state of Delaware. On March 31, 2010, the Company was acquired by CMG Holdings Group, Inc., a Nevada corporation (“CMG”). Effective August 17, 2012, AudioEye Acquisition Corporation, a Nevada corporation (“AEAC”), acquired 80 The Company has developed patented, Internet content publication and distribution software that enables conversion of any media into accessible formats and allows for real time distribution to end users on any Internet connected device. The Company’s focus is to create more comprehensive access to Internet, print, broadcast and other media to all people regardless of their network connection, device, location, or disabilities. The Company is focused on developing innovations in the field of networked and device embedded audio technology. The Company owns a unique patent portfolio comprised of six issued patents in the United States, a notice of allowance from the U.S. Patent and Trademark Office for a seventh patent, and two U.S. patents pending with additional patents being drafted for filing with the U.S. Patent and Trademark Office and internationally. On August 17, 2012, AEAC acquired 80 1. CMG would retain 15 2. CMG would distribute to its stockholders, in the form of a dividend, 5 3. The Company entered into a Royalty Agreement with CMG to pay to CMG 10 4. The Company entered into a Services Agreement with CMG whereby CMG will receive a commission of not less than 7.5 10 On March 22, 2013, the Company and AEAC entered into the Merger Agreement. Pursuant to the Merger Agreement, each share of AEAC common stock issued and outstanding immediately prior to the Merger effective date would be converted into .94134 share of the Company’s common stock and the outstanding convertible debentures of AEAC (the “AEAC Debentures”) in the aggregate principal amount of $ 1,400,200 67,732 24,004,143 5,871,752 On November 12, 2013, the Company and CMG terminated the Royalty Agreement. On December 30, 2013, the Company completed the repurchase of 2,184,583 573,022 50,000

GOING CONCERN AND MANAGEMENT_S

GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS	12 Months Ended
	Dec. 31, 2016
Going Concern [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of December 31, 2016, the Company had cash of $ 1,409,418 2,692,090 786,536 2,340,281 In 2016, the Company sold shares of common stock and warrants for net proceeds, after commissions and other costs, of $ 2,129,082 The Company expects that cash used in operations will decrease significantly over the next several years as the Company executes its business plan. In the event that the Company is not able to fully achieve its plan, the Company may need to raise additional funds through equity or debt financing. If the Company is unsuccessful in raising additional financing, it will need to reduce costs and operations in the future. Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 3 — SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Empire Technologies, LLC (“Empire”). All significant inter-company accounts and transactions have been eliminated. During the years ended December 31, 2016 and 2015, Empire had no activity. Empire had no assets or liabilities as of December 31, 2016 and December 31, 2015. The Company acquired 19.5 The Company expenses development costs for research and development until such time as the software became technologically feasible. The Company’s software became technologically feasible at the end of 2013. The software development was substantially completed by the end of August, 2014. The Company further determined that the life of the capitalized software development costs is three years. Further enhancements and Patentable improvements were developed in 2015 and are ongoing. New patents have been filed and are pending as discussed more fully in the Business Description. Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract. The Company had two major customers including their affiliates which generated approximately 45.3 23.8 21.5 67.5 56.3 11.2 At December 31, 2016, the Company had two customers representing 29 18 The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Research and technology expenses are expensed in the period costs are incurred. For the year ended December 31, 2016 and 2015, research and technology expenses totaled $ 343,712 375,817 Revenue is recognized as a portion of the contract term as services are delivered, and deferred revenue is recorded, only upon the receipt of cash. Timing and accounts affected by the respective journal entry are triggered when payment is received and applied to invoices in accounts receivable. There were no long-term contracts in process as of December 31, 2016 and 2015. Certain reclassifications have been made to prior periods’ data to conform to the current year’s presentation. These reclassifications had no effect on reported income or losses. The Company has a fiscal year ending on December 31. The Company considers cash in savings accounts to be cash equivalents. The Company considers any short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents. The Company has elected the fair value option under ASC 825 for its marketable securities. Marketable securities are classified as available for sale and consist of common stock holdings of publicly traded companies. These securities are marked to market at the end of each reporting period based on the closing price of the security at each balance sheet date. Changes in fair value are recorded as unrealized gains or losses in the consolidated statement of operations in accordance with ASC 320. From time to time, the Company invests in the securities of other entities where there exists no active market for the securities held. Non-marketable securities are recorded at the cost of the investment. The Company establishes an allowance for bad debts through a review of several factors including historical collection experience, current aging status of the customer accounts, and financial condition of the Company’s customers. The Company does not generally require collateral for its accounts receivable. There was an allowance for doubtful accounts of $- 0 Property and equipment are carried at the cost of acquisition or construction and depreciated over the estimated useful lives of the assets. Costs associated with repairs and maintenance are expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of the Company’s property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are 5 7 Goodwill is carried at cost and is not amortized. The Company tests goodwill for impairment on an annual basis at the end of each fiscal year, relying on a number of factors including operating results, business plans, economic projections, anticipated future cash flows and marketplace data. Company management uses its judgment in assessing whether goodwill has become impaired between annual impairment tests according to specifications set forth in ASC 350. The Company completed an evaluation of goodwill at December 31, 2016 and 2015 and determined that there was no impairment. The fair value of the Company’s reporting unit is dependent upon the Company’s estimate of future cash flows and other factors. The Company’s estimates of future cash flows include assumptions concerning future operating performance and economic conditions and may differ from actual future cash flows. Estimated future cash flows are adjusted by an appropriate discount rate derived from the Company’s market capitalization plus a suitable control premium at date of the evaluation. The financial and credit market volatility directly impacts the Company’s fair value measurement through the Company’s weighted average cost of capital that the Company uses to determine its discount rate and through the Company’s stock price that the Company uses to determine its market capitalization. Therefore, changes in the stock price may also affect the amount of impairment recorded. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value. The Company reviews its long-lived assets, including property and equipment, identifiable intangibles, and goodwill annually or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows will be less than the carrying amount of the assets. The Company’s long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long-lived assets were evaluated for impairment and no impairment losses were incurred during the years ended December 31, 2016 and 2015, respectively. The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is estimated at the earlier of a commitment date of completion of services. The non-employee awards are generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company has net operating loss carryforwards available to reduce future taxable income. Future tax benefits for these net operating loss carryforwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that the Company will not realize a future tax benefit, a valuation allowance is established. Basic earnings (loss) per share are computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share and basic earnings (loss) per share are not included in the net loss per share computation until the Company has Net Income. Diluted loss per share including the dilutive effects of common stock equivalents on an “as if converted” basis would reduce the loss per share and thereby be antidilutive. The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2016 and 2015, the Company did not have any derivative instruments that were designated as hedges. On October 9, 2015, the Company issued convertible promissory notes representing $ 2,500,000 25,000,000 0.10 5 1,752,000 0.25 5 In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At December 31, 2016 and 2015, the derivative liability was stated at $ 3,478,626 439,361 2,758,488 The carrying amount of the Company’s financial instruments, consisting of cash equivalents, short-term investments, account and notes receivable, accounts and notes payable, short-term borrowings and certain other liabilities, approximate their fair value due to their relatively short maturities. The carrying amount of the Company’s long-term debt approximates fair value since the stated rate of interest approximates a market rate of interest. Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company. Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability. An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities. In October and November 2015, the Company issued warrants with an exercise price of $ 0.10 0.10 The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $ 0.031 0.058 102 1.14 1.75 5 In 2016, the Company issued warrants with an exercise price of $ 0.25 0.25 The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $ 0.150 0.195 169 178 1.22 1.55 5 280,777 At December 31, 2016, the price of the Company stock was 0.14 175.57 1.47 1.93 3.77 4.97 3,478,626 2,758,488 Fair Value Fair Value Hierarchy Assets Marketable securities, December 31, 2016 $ 1,200 Level 1 Marketable securities, December 31, 2015 $ 3,600 Level 1 Liabilities Derivative Liability , December 31, 2016 $ 3,478,626 Level 3 Derivative Liability , December 31, 2015 $ 439,361 Level 3 There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

MARKETABLE AND NON-MARKETABLE S

MARKETABLE AND NON-MARKETABLE SECURITIES	12 Months Ended
	Dec. 31, 2016
Marketable Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	NOTE 4 — MARKETABLE AND NON-MARKETABLE SECURITIES During 2014, the Company converted $ 60,000 600,000 60,000 24,000 1,200 3,600 36,000 2,400 10,200 During 2014, the Company entered into a licensing transaction where it received 1,200,000 0 1,200,000 During 2014, the Company invested $ 50,000 97,500 50,000 60,000 97,500 At December 31, 2016, the Company management performed an evaluation of its investment in Cannonball Red for purposes of determining the implied fair value of the asset at December 31, 2016. The test indicated that the recorded book value of its investment exceeded its fair value for the year ended December 31, 2016. As a result, upon completion of the assessment, management recorded a non-cash impairment charge of $ 50,000 0

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 5 — PROPERTY AND EQUIPMENT December 31, December 31, 2016 2015 Computers and peripherals $ 25,478 $ 25,478 Accumulated deprecation (25,478) (25,478) Property, plant and equipment, net $ - $ - Depreciation expense totaled $- 0 651

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 6 — INTANGIBLE ASSETS For the years ended December 31, 2016 and 2015, the Company invested in Patents in the amounts of $ 42,640 43,689 Patents, technology and other intangibles with contractual terms are generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted. Software development costs are amortized over their estimated useful life of three years. December 31, December 31, 2016 2015 Patents $ 3,697,710 $ 3,655,070 Capitalized software development 621,567 621,567 Accumulated amortization (2,006,028) (1,435,781) Intangible assets, net $ 2,313,249 $ 2,840,856 Amortization expense for patents totaled $ 373,398 361,133 196,849 172,436 Total amortization expense totaled $ 570,247 533,569

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 7 — RELATED PARTY TRANSACTIONS Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors As of December 31, 2016 and 2015, the Company owed Dr. Bettis $ 20,575 72,944 500 6,000 1,000 0 1,000 8,000 Sean Bradley, President, Chief Technology Officer, and Secretary As of December 31, 2016 and 2015, the Company owed Sean Bradley $ 3,543 6,250 David Moradi As of December 31, 2015 the Company owed David Moradi $ 70,000 4,280 During the year ended December 31, 2016, the Company incurred a total of $ 44,912 Conversion of convertible notes payable On April 18, 2016, the Company issued 2,506,849 200,000 10,575 On April 18, 2016, the Company issued 1,251,142 100,000 5,096 On April 18, 2016, the Company issued an aggregate of 18,353,310 0.175 1,475,000 66,678 Sales of common stock In 2016, the Company sold to CSB IV Holdings, a company under the control of Carr Bettis, an aggregate of 2,607,143 292,000 0.25 365,000 In 2016, the Company sold to Ernest Purcell, a member of the Company’s Board of Directors, 1,607,137 180,000 0.25 225,000 In 2016, the Company sold to Todd Bankofier, the Company’s Chief Executive Officer, 178,571 20,000 0.25 25,000 In 2016, the Company sold to Anthon Capital Management, an entity under the control of David Moradi, 892,857 100,000 0.25 125,000 Other The Company holds 60,000 60,000 50,000 97,500 50,000 97,500 0 In summary, as of December 31, 2016 and 2015, the total balances of related party payable were $ 32,118 153,474

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2016
Notes Payable [Abstract]
Debt Disclosure [Text Block]	NOTE 8 — NOTES PAYABLE 23,800 0 24,000 1,923,499 December 31, December 31, Notes and loans payable 2016 2015 Short Term Maryland TEDCO $ 23,800 $ 24,000 Total $ 23,800 $ 24,000 Long Term Convertible Secured Note (net of unamortized discounts of $600,301 in 2015) - 1,899,699 Maryland TEDCO $ - $ 23,800 Total $ - $ 1,923,499 As of December 31, 2012, the Company had an outstanding loan to a third party in the amount of $ 74,900 25 74,900 149,800 2,000 23,800 47,800 23,800 24,000 0 23,800 24,000 On October 9, 2015 (the “Initial Closing Date”), AudioEye, Inc. (the “Company”) entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) for the issuance and sale of convertible promissory notes in an aggregate principal amount of up to $ 3,750,000 37,500,000 2,500,000 The Notes mature three years from the date of issuance (the “Maturity Date”) and, until the Notes are repaid or converted into shares of the Company’s equity securities (“Equity Securities”), accrue payable-in-kind interest at the rate of 10 1,000,000 60 The Notes contained customary events of default provisions. In connection with the issuance of the Notes, on October 9, 2015, the Company entered into a Security Agreement with the Investors (the “Security Agreement”) pursuant to which the Company granted a security interest in all of its assets to the Investors as collateral for the Company’s obligations under the Notes. As noted below, on April 18, 2016, the parties agreed to remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement. The Warrants are exercisable at $ 0.10 During 2015, the Company issued notes under this offering totaling $ 2,500,000 627,293 600,301 and $ 26,992 2,000,000 1,000,000 On April 18, 2016, the Company issued an aggregate of 12,834,800 18,353,310 2,500,000 119,801 0.001 At the date of conversion, the Company determined that the conversion price of $ 0.84 1,025,000 3,205,959 1,541,678 1,664,281 0.175 178 1.24 5

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 9 — COMMITMENTS AND CONTINGENCIES Operating leases The Company’s principal executive offices are located at 5210 E. Williams Circle, Suite 750, Tucson, Arizona 85711, consisting of approximately 2,362 4,724 5,474 2,763 3,937 21,135 1,280 7,146 500 Rent expense charged to operations, which differs from rent paid due to rent credits and to increasing amounts of base rent, is calculated by allocating total rental payments on a straight-line basis over the term of the lease. During the years ended December 31, 2016 and 2015, rent expense was $ 109,340 314,485 14,657 0 Year ended December 31, 2017 $ 111,603 2018 105,168 2019 37,719 Total $ 254,490 Employment contracts Nathaniel Bradley 200,000 In April 2015, two shareholder class action lawsuits were filed against us and our former officer Nathaniel Bradley and former officer Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon. The complaints seek, among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court has appointed a lead plaintiff and lead counsel. We have responded to the complaints and also filed a motion to dismiss. We believe that the lawsuits have no merit and intend to mount a vigorous defense. Given the current stage of the proceedings in this case, our management currently cannot assess the probability of losses, or reasonably estimate the range of losses, related to these matters. As of December 31, 2015, we have paid the deductible pursuant to the D&O insurance policy, in the amount of $ 100,000 Effective April 24, 2015, Nathaniel Bradley resigned as Chief Executive Officer and President of the Company. Effective with his resignation as Chief Executive Officer and President, the Company’s board of directors appointed Mr. Bradley to serve as Founder and Chief Innovation Officer as well as Treasurer of the Company. Effective May 1, 2015, Mr. Bradley agreed to reduce his annual base salary to $ 125,000 Effective August 27, 2015 Mr. Bradley resigned from his position as Chief Innovation Officer and member of the board of directors. Sean Bradley Effective April 24, 2015, the Company’s board of directors appointed Sean Bradley to serve as President of the Company as well as continuing as Chief Technology Officer and Secretary. Effective May 1, 2015, Mr. Bradley agreed to reduce his annual base salary to $ 150,000 6,250 1,500,000 100 The Company’s board or committee shall in its sole discretion establish goals as to specific matters and amounts with respect to a performance period. The performance options shall have a term of five years from the date of grant and the exercise price shall be determined by using a 10-day average closing price of the company’s common stock over the ten (10) trading days beginning on January 4, 2016, which the committee has determined to be and the Board agrees is an amount that is not less than the fair market value of a share of the common stock of the company on such date. The Board also approved the grant to Mr. Bradley of a long-term equity component of his compensation in the form of an RSU with a seven-year term representing the right to receive, subject to the terms and upon the conditions of the RSU, 150,000 James Crawford 185,000 Effective April 24, 2015, James Crawford resigned as Chief Operating Officer and Treasurer of the Company. Also on April 24, 2015, the Company and Crawdad, LLC. (“Crawdad”), a limited liability company wholly owned by Mr. Crawford, entered into a Consulting Agreement pursuant to which Crawdad, through Mr. Crawford, is to provide certain consulting services to the Company for a period of 12 months for a consulting fee of $ 5,000 The consulting agreement with Crawdad was terminated by mutual agreement on December 31, 2015. Edward O’Donnell 165,000 Effective March 29, 2015, Edward O’Donnell resigned from his position as our Chief Financial Officer. Constantine Potamianos 150,000 On August 7, 2015 Constantine Potamianos employment contract expired. Paul Arena 275,000 35,000 50,000 Mr. Arena was granted five year warrants to purchase 250,000 0.40 1,500,000 0.40 3,000,000 1,500,000 35 35 30 75 1,000,000 3,000,000 125 On March 5, 2015, the Company and Paul Arena entered into a Separation and Release Agreement (the “Separation Agreement”) pursuant to which Mr. Arena resigned as Executive Chairman/Chairman of the Board and a member of the Board of Directors. Under the Separation Agreement, the Company and Mr. Arena agreed that, pursuant to his Stock Option Agreement with the Company, options to purchase 500,000 500,000 500,000 Fifty percent of the options under the Second Tranche are subject to certain clawback provisions as set forth in the Separation Agreement. Additionally, Mr. Arena was being granted 500,000 shares of the Company’s restricted Common Stock (the “Restricted Shares”) with 250,000 50,000 Also on March 5, 2015, the Company and AIM Group, Inc. (“AIM”), a corporation wholly owned by Mr. Arena, entered into a Consulting Agreement (the “Consulting Agreement”) pursuant to which AIM, through Mr. Arena, is to provide certain consulting services to the Company for a period of one year. Under the Consulting Agreement, AIM was to receive a one-time net payment of $ 267,000 425,000 54,892 479,892 250,909 Dr. Carr Bettis . 175,000 750,000 The compensation committee established a target number of shares of 2,000,000 100 On December 7, 2016, the Company’s Board of Directors approved an extension to and modification of the existing employment contract with Dr. Carr Bettis, as well as the grant of certain equity awards to Dr. Bettis under the Company’s 2016 Incentive Compensation Plan. To best preserve the Company’s limited cash resources, the Employment Contract provides generally that Dr. Bettis’s base compensation is paid in the form of Restricted Stock Units (RSU’s). In its December 7, 2016 action by written consent, the Company’s Board of Directors approved an award of RSU’s to Dr. Bettis in consideration of services Dr. Bettis rendered subsequent to June 30, 2016. The number of Employment Contract RSUs awarded was 602,620 72,917 0.121 The Board also approved the grant to Dr. Bettis of a long-term equity component of his compensation in the form of an RSU with a seven-year term representing the right to receive, subject to the terms and upon the conditions of the RSU, 250,000 shares of the Company’s Common Stock, with such number of shares to be reduced by the number of shares, if any, that are awarded to Dr. Bettis in connection with the Performance Option Unit Agreement granted Dr. Bettis in January 2016 under the 2016 Plan. This RSU is also subject to the Award Vesting Conditions. Todd Bankofier 125,000 The compensation committee established a target number of shares of 2,000,000 100 On December 7, 2016, the Company’s Board of Directors approved an increase to the base salary of Todd Bankofier, the Company’s Chief Executive Officer. Mr. Bankofier’s base annual salary was increased to $ 175,000 250,000 Litigation In April 2015, two shareholder class action lawsuits were filed against the Company and former officers Nathaniel Bradley and Edward O’Donnell in the U.S. District Court for the District of Arizona. The plaintiffs allege various causes of action against the defendants arising from our announcement that our previously issued financial results for the first three quarters of 2014 and the guidance for the fourth quarter of 2014 and the full year of 2014 could no longer be relied upon. The complaints sought among other relief, compensatory damages and plaintiff’s counsel’s fees and experts’ fees. The Court appointed a lead plaintiff and lead counsel, and consolidated the actions. A consolidated amended complaint was filed under the caption In re AudioEye, Inc. Sec. Litigation. On July 25, 2016, in connection with a voluntary mediation, the parties reached an agreement in principle to settle the consolidated actions. The settlement agreement is subject to definitive documentation, shareholder notice, and court approval. The terms of the agreement include a settlement payment to the class of $ 1,525,000 100,000 On January 23, 2017, the court granted preliminary approval of the settlement pursuant to the terms set forth in the Stipulation of Settlement, provisionally certified a settlement class of shareholders, and directed plaintiffs' counsel to provide notice to that class. The Court will hold a Final Settlement Hearing May 8, 2017 to consider any objections to the Settlement that might be raised by settlement class members, to consider plaintiffs’ counsel's application for an award of fees and costs, and to finally determine whether the Order and Final Judgment as provided under the Stipulation of Settlement should be entered, dismissing the case with prejudice. On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purported to act on behalf of the Company against the Named Individuals. The Company was named as a nominal defendant. The complaint asserted causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint sought, among other relief, compensatory damages, restitution and attorneys’ fees. In October 2016, the Company and Named Defendants filed a motion to dismiss. In response, the Plaintiff voluntarily dismissed the complaint without prejudice. On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserts causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014. As a derivative complaint, the plaintiff-shareholder purports to act on behalf of the Company against the Named Individuals. The Company is named as a nominal defendant. The Company understands that the Named Individuals intend to vigorously defend the lawsuit. The defendants filed a motion to dismiss the complaint in February 2017, which presently is scheduled to be heard in May 2017. While the Company believes that its legal defense costs may be reimbursed by the Company’s insurance carrier, no reasonable estimate of the outcome of the litigation, the related legal fees, or the impact on the financial results of the Company can be made as of the date of this statement. We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Attributable to Parent [Abstract]
Sale Leaseback Transaction Disclosure [Text Block]	NOTE 10 — STOCKHOLDERS’ EQUITY As of December 31, 2016 and 2015, the Company had 111,521,001 81,717,154 160,000 175,000 10 5 0.1754 On January 15, 2015, the Company sold 812,500 325,000 0.375 304,688 0.60 On March 5, 2015, Paul Arena resigned as Chairman of the Board of Directors and Executive Chairman and was designated by AIM Group, Inc. as a consultant to the Company for the term of one year. The consulting agreement includes a fee of $ 425,000 158,000 267,000 48,000 6,250 12,500 20,000 1,500,000 500,000 500,000 500,000 500,000 3,000,000 250,000 117,500 50 250,000 Commencing on May 1, 2015, the Company sold an aggregate of 175,000 10.00 1,750,000 0.1754 12.50 5 594,641 58,733 On June 2, 2015, the Company granted 1,250,000 200,000 2,000,000 0.16 On June 2, 2015, the Company granted 800,000 128,000 1,000,000 0.16 On October 26, 2015, the Company agreed with its consultant to issue 41,667 41,667 208,332 124,998 In addition to the 2,300,000 801,936 236,626 109,855 43,941 On October 9, 2015 the Company entered into a Note and Warrant Purchase Agreement with accredited investors for the sale of convertible promissory notes in an aggregate principal amount of up to $ 3.75 37.50 2.5 25.0 50 10 The notes plus accrued interest will be automatically converted into equity securities if the Company sells equity securities in a single transaction or series of related transactions for cash of at least $ 2.0 60 0.10 In April 2016, the Company issued an aggregate 83,336 14,292 In April 2016, the Company issued an aggregate of 12,834,800 1,025,000 53,123 In May 2016, the Company sold an aggregate of 11,714,285 1,312,000 1,579,082 63,292 0.25 In May 2016, the Company issued 900,525 15,000 In July 2016, the Company issued an aggregate 124,998 20,666 In August 2016, the Company issued an aggregate 41,666 6,208 In September 2016, the Company issued an aggregate 41,666 6,292 In October 2016, the Company issued an aggregate 41,666 5,208 In November 2016, the Company issued an aggregate 41,666 4,917 In December 2016, the Company issued an aggregate 41,666 5,709 In December 2016, the Company sold an aggregate of 3,928,573 440,000 550,000 0.25 Registration rights Under the purchase agreement, the Company has agreed to use its reasonable best efforts to prepare and file with the SEC registration statement within 60 days of the initial closing date, covering the resale by the investors of any common stock previously issued to the investors, and any common stock into which any convertible promissory notes previously issued to the investors are convertible and any common stock for which the warrants or any warrants previously issued to the investors are exercisable. The Company filed a registration statement on September 30, 2016 and became effective on December 21, 2016. 26,731,207 14,759,914 Intrinsic Wtd Avg. Value Number of Wtd Avg. Remaining of Options Exercise Price Term Exercisable Options Outstanding at December 31, 2014 11,434,350 $ 0.47 3.79 5,635,250 $ 460,941 Granted 8,278,880 0.16 Forfeited/Expired (4,953,316) 0.00 Outstanding at December 31, 2015 14,759,914 $ 0.30 3.61 8,374,294 $ 235,330 Granted 12,508,877 0.09 4.87 — Forfeited/Expired (1,537,584) 0.29 — Outstanding at December 31, 2016 25,731,207 $ 0.20 3.34 15,091,366 $ 1,161,244 On January 15, 2016, the Company granted performance options to acquire shares of the Company’s common stock in aggregate of 6,500,000 0.038 5,500,000 The estimated fair values of the options with performance and market conditions were determined using a Monte Carlo pricing model. Significant assumptions used in the valuation include expected term of 5 162 1.46 0 Nonperformance option grants during the year ended December 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 3.5 102.00 176.77 0.87 1.73 0 On January 4, 2016, the Company issued 500,000 150,000 0.038 January 4, 2019 On April 15, 2016, the Company issued 49,715 0.179 April 15, 2019 6,250 On May 12, 2016, the Company issued 100,000 50 4.17 0.177 May 12, 2021 16,694 On May 12, 2016, the Company issued an aggregate of 3,400,000 50 50 0.177 May 12, 2021 559,603 On June 15, 2016, the Company issued 300,000 options, which vest 50 th June 15, 2021 40,723 On July 15, 2016, the Company issued 56,375 0.156 July 15, 2019 6,250 On October 15, 2016, the Company issued 61,599 0.121 October 15, 2019 5,209 On December 2, 2016, the Company issued an aggregate of 1,391,188 50 25 25 0.121 December 2, 2021 150,875 For the year ended December 31, 2016 and 2015, total stock compensation expense related to the options totaled $ 864,024 823,478 The outstanding unamortized stock compensation expense related to options was $ 482,153 406,157 Warrants Intrinsic Wtd Avg. Value Number of Wtd Avg. Remaining of Warrants Exercise Price Term Warrants Outstanding at December 31, 2014 16,527,989 $ 0.46 3.69 $ 309,821 Granted 28,913,020 0.11 Exercised (109,855) 0.40 Forfeited (2,084,296) 0.43 Outstanding at December 31, 2015 43,246,858 $ 0.22 4.15 $ 1,167 Granted 21,681,264 0.03 4.87 — Forfeited/Expired (1,495,081) 0.48 — Outstanding at December 31, 2016 63,433,041 $ 0.15 3.55 $ 3,662,610 The warrant grants during the year ended December 31, 2016 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 1.5 2.5 166.74 178.98 0.71 1.08 0 During the year ended December 31, 2016, the Company issued an aggregate of 1,575,954 0.038 0.179 150,500 1,492,620 In April 2016, the Company issued an aggregate of 18,353,310 1,541,678 0.001 The Company determined that the estimated fair value of the 18,353,310 3,205,959 1,541,678 1,664,281 0.175 178 1.24 5 In May 2016, the Company issued 1,312,000 0.25 In December 2016, the Company issued 440,000 0.25 For the year ended December 31, 2016 and 2015, the Company has incurred warrant-based expense of $ 221,621 510,436 47,685 106,852 Restricted stock units (“RSU”) Restricted shares issued as of January 1, 2015 - Granted - Total Restricted Shares Issued at December 31, 2015 - Granted 1,252,620 Total Restricted Shares Issued at December 31, 2016 1,252,620 Vested at December 31, 2016 - Unvested restricted shares as of December 31, 2015 1,252,620 In December 7, 2016, the Company granted 602,620 72,917 The Board also approved the grant to an aggregate of 650,000 RSUs to officers with a seven-year term representing the right to receive, subject to the terms and upon the conditions of the RSU, 650,000 shares of the Company’s common stock, with such number of shares to be reduced by the number of shares, if any, that are awarded to Dr. Bettis in connection with the Performance Option Unit Agreement granted Dr. Bettis in January 2016 under the 2016 Plan. These RSU is also subject the following conditions: (i) Officer remains in service to the Company continuously through and until June 30, 2017, and (ii) the Company undergoes a change of control during the seven-year term of the award. The fair value of the 650,000 87,750 due to the performance condition not met. In connection with the issuance of the above described RSUs as payment for accrued compensation, the Company reclassified to equity the outstanding salary accrual of $ 72,917

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 11 — INCOME TAXES The Company accounts for income taxes under ASC 740, “Income Taxes”. Temporary differences are differences between the tax basis of assets and liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is recorded when the ultimate realization of a deferred tax as The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below: December 31, December 31, Deferred tax assets: 2016 2015 Net operating loss carry forwards $ 7,558,530 $ 6,373,434 Less valuation allowance (7,558,530) (6,373,434) Net deferred tax asset $ 0 $ 0 At this time, the Company is unable to determine if it will be able to benefit from its deferred tax asset. There are limitations on the utilization of net operating loss carry forwards, including a requirement that losses be offset against future taxable income, if any. In addition, there are limitations imposed by certain transactions, which are deemed to be ownership changes. Accordingly, a valuation allowance has been established for the entire deferred tax asset. The approximate net operating loss carry forward was $ 22,230,971 18,745,343 . The Company’s tax return for the year 2013, 2014 and 2015 are open to IRS inspection

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 12 — SUBSEQUENT EVENTS Employee options/warrants On January 3, 2017, the Company granted 100,000 0.159 50 50 On January 14, 2017, the Company issued 250,000 0.12 On March 10, 2017, the Company granted 100,000 0.145 50 50 Common stock In January 2017, the Company issued 41,666 6,625 In January 2017, the Company sold 357,143 40,000 50,000 0.25 In February 2017, the Company issued 41,666 5,333 In March 2017, the Company issued 41,666 5,917 Restricted stock units (“RSU”) In February 23, 2017, the Company granted 402,297 58,333

SIGNIFICANT ACCOUNTING POLICI21

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Empire Technologies, LLC (“Empire”). All significant inter-company accounts and transactions have been eliminated. During the years ended December 31, 2016 and 2015, Empire had no activity. Empire had no assets or liabilities as of December 31, 2016 and December 31, 2015. The Company acquired 19.5
Research, Development, and Computer Software, Policy [Policy Text Block]	Capitalization of Software Development Costs The Company expenses development costs for research and development until such time as the software became technologically feasible. The Company’s software became technologically feasible at the end of 2013. The software development was substantially completed by the end of August, 2014. The Company further determined that the life of the capitalized software development costs is three years. Further enhancements and Patentable improvements were developed in 2015 and are ongoing. New patents have been filed and are pending as discussed more fully in the Business Description.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Revenue is recognized when all applicable recognition criteria have been met, which generally include (a) persuasive evidence of an existing arrangement; (b) fixed or determinable price; (c) delivery has occurred or service has been rendered; and (d) collectability of the sales price is reasonably assured. For software and technology development contracts the Company recognizes revenues on a percentage of completion method based upon several factors including but not limited to (a) estimate of total hours and milestones to complete; (b) total hours completed; (c) delivery of services rendered; (d) change in estimates; and (e) collectability of the contract. The Company had two major customers including their affiliates which generated approximately 45.3 23.8 21.5 67.5 56.3 11.2 At December 31, 2016, the Company had two customers representing 29 18
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Research and Development Expense, Policy [Policy Text Block]	Research and Technology Expenses Research and technology expenses are expensed in the period costs are incurred. For the year ended December 31, 2016 and 2015, research and technology expenses totaled $ 343,712 375,817
Revenue Recognition, Long-term Contracts [Policy Text Block]	Billings in Excess of Revenues Revenue is recognized as a portion of the contract term as services are delivered, and deferred revenue is recorded, only upon the receipt of cash. Timing and accounts affected by the respective journal entry are triggered when payment is received and applied to invoices in accounts receivable. There were no long-term contracts in process as of December 31, 2016 and 2015.
Reclassification, Policy [Policy Text Block]	Reclassification Certain reclassifications have been made to prior periods’ data to conform to the current year’s presentation. These reclassifications had no effect on reported income or losses.
Fiscal Period, Policy [Policy Text Block]	Fiscal Year End The Company has a fiscal year ending on December 31.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers cash in savings accounts to be cash equivalents. The Company considers any short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents.
Marketable Securities, Policy [Policy Text Block]	Marketable Securities The Company has elected the fair value option under ASC 825 for its marketable securities. Marketable securities are classified as available for sale and consist of common stock holdings of publicly traded companies. These securities are marked to market at the end of each reporting period based on the closing price of the security at each balance sheet date. Changes in fair value are recorded as unrealized gains or losses in the consolidated statement of operations in accordance with ASC 320.
Cost Method Investments, Policy [Policy Text Block]	Non-marketable Securities From time to time, the Company invests in the securities of other entities where there exists no active market for the securities held. Non-marketable securities are recorded at the cost of the investment.
Receivables, Policy [Policy Text Block]	Allowance for Doubtful Accounts The Company establishes an allowance for bad debts through a review of several factors including historical collection experience, current aging status of the customer accounts, and financial condition of the Company’s customers. The Company does not generally require collateral for its accounts receivable. There was an allowance for doubtful accounts of $- 0
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are carried at the cost of acquisition or construction and depreciated over the estimated useful lives of the assets. Costs associated with repairs and maintenance are expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of the Company’s property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are 5 7
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill, Intangible Assets, and Long-Lived Assets Goodwill is carried at cost and is not amortized. The Company tests goodwill for impairment on an annual basis at the end of each fiscal year, relying on a number of factors including operating results, business plans, economic projections, anticipated future cash flows and marketplace data. Company management uses its judgment in assessing whether goodwill has become impaired between annual impairment tests according to specifications set forth in ASC 350. The Company completed an evaluation of goodwill at December 31, 2016 and 2015 and determined that there was no impairment. The fair value of the Company’s reporting unit is dependent upon the Company’s estimate of future cash flows and other factors. The Company’s estimates of future cash flows include assumptions concerning future operating performance and economic conditions and may differ from actual future cash flows. Estimated future cash flows are adjusted by an appropriate discount rate derived from the Company’s market capitalization plus a suitable control premium at date of the evaluation. The financial and credit market volatility directly impacts the Company’s fair value measurement through the Company’s weighted average cost of capital that the Company uses to determine its discount rate and through the Company’s stock price that the Company uses to determine its market capitalization. Therefore, changes in the stock price may also affect the amount of impairment recorded. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value. The Company reviews its long-lived assets, including property and equipment, identifiable intangibles, and goodwill annually or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows will be less than the carrying amount of the assets.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets The Company’s long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long-lived assets were evaluated for impairment and no impairment losses were incurred during the years ended December 31, 2016 and 2015, respectively.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock based compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is estimated at the earlier of a commitment date of completion of services. The non-employee awards are generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.
Income Tax, Policy [Policy Text Block]	Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company has net operating loss carryforwards available to reduce future taxable income. Future tax benefits for these net operating loss carryforwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that the Company will not realize a future tax benefit, a valuation allowance is established.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) Per Share Basic earnings (loss) per share are computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share and basic earnings (loss) per share are not included in the net loss per share computation until the Company has Net Income. Diluted loss per share including the dilutive effects of common stock equivalents on an “as if converted” basis would reduce the loss per share and thereby be antidilutive.
Derivatives, Policy [Policy Text Block]	Derivative Instrument Liability The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2016 and 2015, the Company did not have any derivative instruments that were designated as hedges. On October 9, 2015, the Company issued convertible promissory notes representing $ 2,500,000 25,000,000 0.10 5 1,752,000 0.25 5 In accordance with ASC 815, these outstanding warrants are deemed to contain embedded derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheets. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations. This is a non-cash income (expense) item and is adjusted in the “operating activities” of the Consolidated Statements of Cash Flow. At December 31, 2016 and 2015, the derivative liability was stated at $ 3,478,626 439,361 2,758,488
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments The carrying amount of the Company’s financial instruments, consisting of cash equivalents, short-term investments, account and notes receivable, accounts and notes payable, short-term borrowings and certain other liabilities, approximate their fair value due to their relatively short maturities. The carrying amount of the Company’s long-term debt approximates fair value since the stated rate of interest approximates a market rate of interest.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements Fair value is an estimate of the exit price, representing the amount that would be received to, sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels: Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company. Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability. An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities. In October and November 2015, the Company issued warrants with an exercise price of $ 0.10 0.10 The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $ 0.031 0.058 102 1.14 1.75 5 In 2016, the Company issued warrants with an exercise price of $ 0.25 0.25 The Company estimated the fair value of these derivative warrants at initial issuance and again at each balance sheet date. The changes in fair value are recognized in earnings in the Consolidated Statements of Operations under the caption “unrealized gain/(loss) – derivative liability” until such time as the derivative warrants are exercised or expire. The Company used the Black-Scholes Option Pricing model to estimate the fair value of the dates of issuance, the price of the Company stock ranged $ 0.150 0.195 169 178 1.22 1.55 5 280,777 At December 31, 2016, the price of the Company stock was 0.14 175.57 1.47 1.93 3.77 4.97 3,478,626 2,758,488 Fair Value Fair Value Hierarchy Assets Marketable securities, December 31, 2016 $ 1,200 Level 1 Marketable securities, December 31, 2015 $ 3,600 Level 1 Liabilities Derivative Liability , December 31, 2016 $ 3,478,626 Level 3 Derivative Liability , December 31, 2015 $ 439,361 Level 3
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

SIGNIFICANT ACCOUNTING POLICI22

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value Fair Value Hierarchy Assets Marketable securities, December 31, 2016 $ 1,200 Level 1 Marketable securities, December 31, 2015 $ 3,600 Level 1 Liabilities Derivative Liability , December 31, 2016 $ 3,478,626 Level 3 Derivative Liability , December 31, 2015 $ 439,361 Level 3

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment consist of the following: December 31, December 31, 2016 2015 Computers and peripherals $ 25,478 $ 25,478 Accumulated deprecation (25,478) (25,478) Property, plant and equipment, net $ - $ -

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Prior to any impairment adjustment, intangible assets consisted of the following: December 31, December 31, 2016 2015 Patents $ 3,697,710 $ 3,655,070 Capitalized software development 621,567 621,567 Accumulated amortization (2,006,028) (1,435,781) Intangible assets, net $ 2,313,249 $ 2,840,856

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Payable [Abstract]
Schedule of Debt [Table Text Block]	As of December 31, 2016 and 2015, the Company has short term and long term notes payable of $ 23,800 0 24,000 1,923,499 December 31, December 31, Notes and loans payable 2016 2015 Short Term Maryland TEDCO $ 23,800 $ 24,000 Total $ 23,800 $ 24,000 Long Term Convertible Secured Note (net of unamortized discounts of $600,301 in 2015) - 1,899,699 Maryland TEDCO $ - $ 23,800 Total $ - $ 1,923,499

COMMITMENTS AND CONTINGENCIES(T

COMMITMENTS AND CONTINGENCIES(Tables)	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	The following is a schedule of future minimum lease payments for all non-cancelable operating leases for each of the next three years ending December 31 and thereafter: Year ended December 31, 2017 $ 111,603 2018 105,168 2019 37,719 Total $ 254,490

STOCKHOLDERS_ EQUITY(Tables)

STOCKHOLDERS’ EQUITY(Tables)	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Attributable to Parent [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	As of December 31, 2016 and 2015, the Company has outstanding options to purchase 26,731,207 14,759,914 Intrinsic Wtd Avg. Value Number of Wtd Avg. Remaining of Options Exercise Price Term Exercisable Options Outstanding at December 31, 2014 11,434,350 $ 0.47 3.79 5,635,250 $ 460,941 Granted 8,278,880 0.16 Forfeited/Expired (4,953,316) 0.00 Outstanding at December 31, 2015 14,759,914 $ 0.30 3.61 8,374,294 $ 235,330 Granted 12,508,877 0.09 4.87 — Forfeited/Expired (1,537,584) 0.29 — Outstanding at December 31, 2016 25,731,207 $ 0.20 3.34 15,091,366 $ 1,161,244
Schedule of Other Share-based Compensation, Activity [Table Text Block]	Below is a table summarizing the Company’s outstanding warrants as of December 31, 2016 and December 31, 2015: Intrinsic Wtd Avg. Value Number of Wtd Avg. Remaining of Warrants Exercise Price Term Warrants Outstanding at December 31, 2014 16,527,989 $ 0.46 3.69 $ 309,821 Granted 28,913,020 0.11 Exercised (109,855) 0.40 Forfeited (2,084,296) 0.43 Outstanding at December 31, 2015 43,246,858 $ 0.22 4.15 $ 1,167 Granted 21,681,264 0.03 4.87 — Forfeited/Expired (1,495,081) 0.48 — Outstanding at December 31, 2016 63,433,041 $ 0.15 3.55 $ 3,662,610
Nonvested Restricted Stock Shares Activity [Table Text Block]	The following table summarizes the restricted stock activity for the two years ended December 31, 2015: Restricted shares issued as of January 1, 2015 - Granted - Total Restricted Shares Issued at December 31, 2015 - Granted 1,252,620 Total Restricted Shares Issued at December 31, 2016 1,252,620 Vested at December 31, 2016 - Unvested restricted shares as of December 31, 2015 1,252,620

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, December 31, Deferred tax assets: 2016 2015 Net operating loss carry forwards $ 7,558,530 $ 6,373,434 Less valuation allowance (7,558,530) (6,373,434) Net deferred tax asset $ 0 $ 0

ORGANIZATION (Details Textual)

ORGANIZATION (Details Textual)	1 Months Ended
	Dec. 30, 2013USD ($)shares	Mar. 22, 2013USD ($)shares	Aug. 17, 2012
Affiliate Of C M G Holdings Groups Inc [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Debt Instrument, Decrease, Forgiveness	$ 50,000
Audio Eye Acquisition Corporation [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Sale of Stock, Percentage of Ownership after Transaction			80.00%
Debt Conversion Accrued Interest On Debt Amount1		$ 67,732
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued To Debenture Holders | shares		5,871,752
Debt Conversion, Original Debt, Amount		$ 1,400,200
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares		24,004,143
Merger With Aeac Conversion Rate Of Stock		0.94134
C M G Holdings Group Inc [Member]
Organization, Consolidation and Presentation of Financial Statements [Line Items]
Spin Off Stock holders Dividend			5.00%
Royalty Percentage Separation And Spin Off			10.00%
Commission Percentage Separation And Spin Off			7.50%
Commission Percentage Separation And Spin Off Specified			10.00%
Sale of Stock, Percentage of Ownership after Transaction			80.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			15.00%
Stock Repurchased and Retired During Period, Shares | shares	2,184,583
Stock Repurchased During Period, Value	$ 573,022

GOING CONCERN AND MANAGEMENT_30

GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Going Concern And Management Liquidity Plans [Line Items]
Working Capital Amount	$ 2,692,090
Working Capital	786,536
Cash	1,409,418	$ 1,687,257
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total	(2,340,281)	$ (5,474,454)
Proceeds from Issuance or Sale of Equity	$ 2,129,082

SIGNIFICANT ACCOUNTING POLICI31

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in related party	$ 1,200	$ 3,600
Derivative Liability, Fair Value, Gross Liability	627,293
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in related party	1,200	3,600
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Notional Amount	$ 3,478,626
Derivative Liability, Fair Value, Gross Liability		$ 439,361

SIGNIFICANT ACCOUNTING POLICI32

SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)	Oct. 09, 2015	Dec. 31, 2016	May 31, 2016	Nov. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2012	Apr. 30, 2016	Nov. 08, 2015	May 01, 2015
Summary Of Significant Accounting Policies [Line Items]
Payments to Acquire Businesses and Interest in Affiliates, Total					$ 3,478,626
Research and Development Expense, Total					343,712	$ 375,817
Allowance for Doubtful Accounts Receivable		$ 0			$ 0	0
Common Stock Issuance Price Per Share				$ 0.10	$ 0.25
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10	$ 0.25	$ 0.25	$ 0.10	0.25			$ 0.001
Share Price		$ 0.14			$ 0.14					$ 10
Fair Value Assumptions, Weighted Average Volatility Rate				102.00%	175.57%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years			5 years	5 years
Fair Value Adjustment of Warrants					$ 280,777
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Change in Unrealized Gain (Loss)					2,758,488
Class Of Warrant Or Right Exercisable Number	25,000,000
Stock Issued During Period Value Warrants Exercised	1,752,000		1,312,000
Debt Instrument, Face Amount	$ 2,500,000								$ 149,800
Derivative Liability, Current		$ 3,478,626			3,478,626	439,361
Unrealized Gain (Loss) on Derivatives					$ (2,758,488)	$ 187,932
Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.25	$ 0.25		$ 0.25
Fair Value Assumptions, Weighted Average Volatility Rate	0.25%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years
Stock Issued During Period Value Warrants Exercised		440,000	1,312,000
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life					5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.038			$ 0.038
Share Price		0.150		$ 0.031	$ 0.150
Fair Value Assumptions, Weighted Average Volatility Rate					169.00%
Fair Value Assumptions, Risk Free Interest Rate				1.14%	1.47%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					3 years 9 months 7 days
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life					7 years
Class of Warrant or Right, Exercise Price of Warrants or Rights		0.179			$ 0.179
Share Price		$ 0.195		$ 0.058	$ 0.195
Fair Value Assumptions, Weighted Average Volatility Rate					178.00%
Fair Value Assumptions, Risk Free Interest Rate				1.75%	1.93%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					4 years 11 months 19 days
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage					45.30%	67.50%
Customer One [Member] | Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage					29.00%
Customer Two [Member] | Accounts Receivable [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage					18.00%
Major Customer Number One [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage					23.80%	56.30%
Major Customer Number Two [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage					21.50%	11.20%
Couponicate [Member]
Summary Of Significant Accounting Policies [Line Items]
Sale of Stock, Percentage of Ownership after Transaction							19.50%

MARKETABLE AND NON-MARKETABLE33

MARKETABLE AND NON-MARKETABLE SECURITIES (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Marketable Securities, Current, Total	$ 1,200	$ 3,600
Marketable Securities, Unrealized Gain (Loss), Total	(2,400)	(10,200)
Investment Owned, at Cost	0	50,000	$ 50,000
Other than Temporary Impairment Losses, Investments	50,000	$ 0
Ecologic Transportation [Member]
Number Of Shares Note Is Convertible Of Company			600,000
Investment Amount From Conversion Of Accounts Receivable			$ 60,000
Peartrack Security Systems Inc [Member]
Investment Owned, Balance, Shares		60,000
Investment Owned, at Fair Value		$ 24,000
Marketable Securities, Current, Total	1,200	3,600
Loss On Conversion Of Accounts Receivable To Marketable Securities			$ 36,000
Marketable Securities, Unrealized Gain (Loss), Total	2,400	10,200
Cannonball Red [Member]
Investment Owned, Balance, Shares			97,500
Investment Owned, at Cost	97,500	97,500	$ 50,000
Repurchase Amount Of Cost Method Investment			$ 60,000
Other than Temporary Impairment Losses, Investments	$ 50,000	$ 0
Beta Music Group [Member]
Investment Owned, Balance, Shares	1,200,000		1,200,000
Investment Owned, at Cost			$ 0

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Accumulated deprecation	$ (25,478)	$ (25,478)
Property, plant and equipment, net	0	0
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computers and peripherals	$ 25,478	$ 25,478

PROPERTY AND EQUIPMENT (Detai35

PROPERTY AND EQUIPMENT (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Depreciation	$ 0	$ 651

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Intangible Assets
Accumulated amortization	$ (2,006,028)	$ (1,435,781)
Intangible assets, net	2,313,249	2,840,856
Patents
Intangible Assets
Finite-Lived Intangible Assets, Gross	3,697,710	3,655,070
Capitalized software development
Intangible Assets
Finite-Lived Intangible Assets, Gross	$ 621,567	$ 621,567

INTANGIBLE ASSETS (Details Text

INTANGIBLE ASSETS (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 600,301	$ 26,992
Software Development Costs
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	570,247	533,569
Amortization of Intangible Assets	196,849	172,436
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,697,710	3,655,070
Amortization of Intangible Assets	373,398	361,133
Finite-lived Intangible Assets Acquired	$ 42,640	$ 43,689

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	1 Months Ended						12 Months Ended
	Dec. 31, 2016	Nov. 30, 2016	Oct. 31, 2016	May 31, 2016	Apr. 18, 2016	Mar. 18, 2016	Dec. 31, 2016	Dec. 31, 2015	Apr. 30, 2016	Nov. 30, 2015	Oct. 09, 2015	Dec. 31, 2014
Cost method investment	$ 0						$ 0	$ 50,000				$ 50,000
Related party payables	$ 32,118						$ 32,118	153,474
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25			$ 0.25			$ 0.25		$ 0.001	$ 0.10	$ 0.10
Stock Issued During Period, Shares, New Issues	41,666	41,666	41,666	11,714,285
Stock Issued During Period, Value, New Issues	$ 5,709	$ 4,917	$ 5,208
Due To Related Party For Unreimbursed Travel related Expenses	8,000						$ 8,000
Other than Temporary Impairment Losses, Investments							50,000	0
Anthion Management LLC [Member]
Legal Fees							44,912
Convertible Notes Payable [Member]
Debt Conversion, Original Debt, Amount							1,025,000
Accounts Payable and Accrued Liabilities [Member]
Accrued Rent, Current	0						0	1,000
Executive Officer [Member]
Due to Related Parties	$ 20,575						$ 20,575	72,944
Class of Warrant or Right, Warrant Term							5 years
Nathaniel Bradley
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	20,000						20,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25						$ 0.25
Stock Issued During Period, Shares, New Issues							178,571
Stock Issued During Period, Value, New Issues							$ 25,000
Operating Leases, Rent Expense, Net, Total	$ 500						$ 6,000	1,000
Director [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	180,000						180,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25						$ 0.25
Stock Issued During Period, Shares, New Issues							1,607,137
Stock Issued During Period, Value, New Issues							$ 225,000
Class of Warrant or Right, Warrant Term							5 years
Peartrack Security Systems
Related party payables	$ 32,118						$ 32,118	153,474
Shares owned												60,000
Investment Owned, Balance, Shares												60,000
Ecologic Transportation
Conversion of accounts receivable												$ 60,000
Cannonball Red
Cost method investment	$ 0						$ 0					$ 50,000
Shares owned	97,500						97,500					97,500
Other than Temporary Impairment Losses, Investments							$ 50,000
Investment Owned, Balance, Shares	97,500						97,500					97,500
Sean Bradley
Due to Related Parties	$ 3,543						$ 3,543	6,250
David Moradi
Due to Related Parties								70,000
Interest Receivable								$ 4,280
KTK Capital Inc [Member] | Convertible Notes Payable [Member]
Debt Conversion, Original Debt, Amount					$ 200,000
Debt Conversion, Converted Instrument, Shares Issued					2,506,849
Interest Payable, Current					$ 10,575
FBO Alexandre Zynier IRA [Member] | Convertible Notes Payable [Member]
Debt Conversion, Original Debt, Amount					$ 100,000
Debt Conversion, Converted Instrument, Shares Issued					1,251,142
Interest Payable, Current					$ 5,096
Anthion Partners and Anthion Partners II LLC [Member] | Convertible Notes Payable [Member]
Debt Conversion, Original Debt, Amount					$ 1,475,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					18,353,310
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.175
Interest Payable, Current					$ 66,678
CSB IV Holdings [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	292,000						292,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25						$ 0.25
Stock Issued During Period, Shares, New Issues							2,607,143
Stock Issued During Period, Value, New Issues							$ 365,000
Class of Warrant or Right, Warrant Term							2 years
Anthon Capital Management [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	100,000						100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25						$ 0.25
Stock Issued During Period, Shares, New Issues							892,857
Stock Issued During Period, Value, New Issues							$ 125,000
Class of Warrant or Right, Warrant Term						5 years	5 years

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Notes and loans payable
Short Term	$ 23,800	$ 24,000
Long Term	0	1,923,499
Convertible Secured Note (net of unamortized discounts of $600,301 in 2015)	0	1,899,699
Maryland TEDCO Note
Notes and loans payable
Short Term	23,800	24,000
Long Term	$ 0	$ 23,800

NOTES PAYABLE (Details Textual)

NOTES PAYABLE (Details Textual) - USD ($)	Oct. 09, 2015	Dec. 31, 2016	Nov. 30, 2016	Oct. 31, 2016	May 31, 2016	Apr. 30, 2016	Apr. 18, 2016	Oct. 24, 2011	Nov. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Nov. 09, 2015	Nov. 08, 2015	May 01, 2015	Dec. 31, 2012
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 2,500,000												$ 149,800
Notes and Loans Payable, Current, Total		$ 23,800								$ 23,800	$ 24,000
Long-term Debt, Total		$ 0								$ 0	1,923,499
Debt Instrument, Convertible, Conversion Price														$ 0.1754
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10	$ 0.25			$ 0.25	$ 0.001			$ 0.10	$ 0.25
Share Price		$ 0.14								$ 0.14				$ 10
Amortization of Intangible Assets										$ 600,301	26,992
Proceeds from Notes Payable											2,500,000
Derivative Liability, Fair Value, Gross Liability		$ 627,293								627,293
Stock Issued During Period, Shares, New Issues		41,666	41,666	41,666	11,714,285
Debt Conversion, Converted Instrument, Amount										1,078,123	0
Gain (Loss) on Extinguishment of Debt										$ (1,664,281)	0
Fair Value Assumptions, Weighted Average Volatility Rate									102.00%	175.57%
Debt Conversion, Description										In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the Purchase Agreement Amendment) and an Omnibus Amendment to Secured Promissory Notes (the Note Amendment), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the Original Agreement) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, Anthion), entities under the control of David Moradi, to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of qualified financing under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing blocker provisions (Special Warrants) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar blocker provisions.
Blackscholes Option Pricing Model [Member]
Debt Instrument [Line Items]
Share Price		$ 0.175								$ 0.175
Fair Value Assumptions, Expected Term										5 years
Fair Value Assumptions, Risk Free Interest Rate										1.24%
Fair Value Assumptions, Weighted Average Volatility Rate										178.00%
Amendments To Existing Agreements [Member]
Debt Instrument [Line Items]
Interest Payable, Current							$ 119,801
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.001
Warrants Issued During Period Shares							18,353,310
Stock Issued During Period, Shares, New Issues							12,834,800
Debt Conversion, Converted Instrument, Amount							$ 2,500,000
Maximum [Member]
Debt Instrument [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		0.179								$ 0.179
Share Price		0.195							$ 0.058	$ 0.195
Fair Value Assumptions, Risk Free Interest Rate									1.75%	1.93%
Fair Value Assumptions, Weighted Average Volatility Rate										178.00%
Minimum [Member]
Debt Instrument [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		0.038								$ 0.038
Share Price		0.150							$ 0.031	$ 0.150
Fair Value Assumptions, Risk Free Interest Rate									1.14%	1.47%
Fair Value Assumptions, Weighted Average Volatility Rate										169.00%
Note and Warrant Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount												$ 2,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	37,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	10.00%
Notes and Warrants Exercisable Description	Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date.
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Debt Conversion, Original Debt, Amount										$ 1,025,000
Debt Instrument, Convertible, Conversion Price		$ 0.84								$ 0.84
Debt Instrument, Convertible, If-converted Value in Excess of Principal						$ 1,541,678				$ 1,541,678
Gain (Loss) on Extinguishment of Debt										1,664,281
Warrants and Rights Outstanding		$ 3,205,959								3,205,959
Loans Payable
Debt Instrument [Line Items]
Long-term Debt, Gross															$ 74,900
Debt Instrument, Interest Rate, Stated Percentage															25.00%
Interest Payable, Current															$ 74,900
Maryland TEDCO Note
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Total								$ 2,000
Long-term Debt, Gross		23,800								23,800	47,800
Debt Instrument, Face Amount								$ 149,800
Notes and Loans Payable, Current, Total		23,800								23,800	24,000
Long-term Debt, Total		$ 0								0	$ 23,800
Repayments of Long-term Debt, Total										$ 24,000
Notes
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 3,750,000
Debt Conversion Total Issued And Outstanding Common Shares Percent	60.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.10
Proceeds from Sale of Available-for-sale Securities, Equity	$ 1,000,000
Notes | Maximum [Member]
Debt Instrument [Line Items]
Proceeds from Sale of Available-for-sale Securities, Equity	2,000,000
Notes | Minimum [Member]
Debt Instrument [Line Items]
Proceeds from Sale of Available-for-sale Securities, Equity	$ 1,000,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2016USD ($)
2,017	$ 111,603
2,018	105,168
2,019	37,719
Total	$ 254,490

COMMITMENTS AND CONTINGENCIES42

COMMITMENTS AND CONTINGENCIES (Details Textual)

Dec. 07, 2016USD ($)$ / sharesshares

Dec. 02, 2016shares

Jan. 15, 2016shares

Nov. 10, 2015USD ($)shares

Oct. 01, 2015USD ($)

Jul. 03, 2015USD ($)

Jul. 01, 2015

May 01, 2015USD ($)$ / shares

Mar. 05, 2015shares

Mar. 05, 2015USD ($)shares

Sep. 02, 2016USD ($)

Jul. 25, 2016USD ($)

Dec. 22, 2015shares

Oct. 26, 2015shares

Apr. 24, 2015USD ($)

Apr. 24, 2015USD ($)shares

Jan. 27, 2014USD ($)$ / sharesshares

Aug. 07, 2013USD ($)

Dec. 31, 2016USD ($)a$ / sharesshares

Dec. 31, 2015USD ($)shares

Dec. 31, 2014USD ($)

May 31, 2016$ / shares

Apr. 30, 2016$ / shares

Nov. 30, 2015$ / shares

Oct. 09, 2015$ / shares

Commitments And Contingencies [Line Items]

Area Of Principal Executive Offices | a

2,362

Operating Leases, Rent Expense

$ 109,340

$ 314,485

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.25

$ 0.25

$ 0.001

$ 0.10

$ 0.10

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares

1,391,188

6,500,000

Escrow Shares | shares

250,000

Lease Rent Per Month

$ 4,724

$ 5,474

Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability

100,000

Litigation Settlement, Amount

$ 1,525,000

Payments for Legal Settlements

$ 100,000

Deferred Rent Credit

$ 14,657

Accrued Rent

$ 0

Share Price | $ / shares

$ 10

$ 0.14

Share-based Compensation Award, Tranche One [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

50.00%

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares

500,000

Share-based Compensation Award, Tranche Two [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares

50,000

Restricted Stock Units (RSUs) [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

7 years

7 years

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares

250,000

150,000

1,252,620

0

Performance Target | PSUs

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares

1,500,000

Employee Stock Option [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares

1,500,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares

$ 0.40

Sublease in Atlanta [Member]

Commitments And Contingencies [Line Items]

Operating Leases, Rent Expense

$ 2,763

$ 3,937

Sublease in Washington D C [Member]

Commitments And Contingencies [Line Items]

Reduction in Monthly Rent

7,146

Gain (Loss) on Disposition of Business

1,280

Sublease in New York [Member]

Commitments And Contingencies [Line Items]

Operating Leases, Rent Expense, Sublease Rentals

21,135

Sublease in Scottsdale, AZ [Member]

Commitments And Contingencies [Line Items]

Operating Leases, Rent Expense, Sublease Rentals

$ 500

Warrant [Member]

Commitments And Contingencies [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

1,575,954

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.25

$ 0.25

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares

41,667

208,332

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares

21,681,264

28,913,020

Maximum [Member]

Commitments And Contingencies [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.179

Share Price | $ / shares

0.195

0.058

Minimum [Member]

Commitments And Contingencies [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

0.038

Share Price | $ / shares

$ 0.150

$ 0.031

Nathaniel Bradley

Commitments And Contingencies [Line Items]

Base Salary

$ 125,000

$ 200,000

Officers' Compensation

$ 175,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period | shares

2,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

100.00%

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

20,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.25

Nathaniel Bradley | Restricted Stock Units (RSUs) [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

7 years

Sean Bradley

Commitments And Contingencies [Line Items]

Base Salary

$ 195,000

Officers' Compensation

$ 150,000

Executive Employment Agreement Period

3 years

Share Price Condition

(a) satisfaction of a share price condition described below; and (b) 100% achievement of the performance goals by the company and Mr. Bradley, as applicable. Subject to the share price condition, 50% of the target award will be earned by Mr. Bradley at the 85% achievement level, and he can earn up to 150% of the target award at the 125% achievement level. Vesting shall be determined based upon performance measures at the end of each calendar year of 2016 and 2017, with 50% of each target award and performance increase subject to vesting during each performance period.

Performance Objective Description

(a) Targeted cash contract bookings (as to 33.33%); (b) Targeted net operating cash flow (as to 33.33%); (c) Board defined operations goals (as to 33.33%) for a performance period. And, vesting shall only occur if the closing share price of the companys common stock on each of the 20 trading days before and including the end of a performance period is not less than $0.20 per share (as adjusted for stock splits, combinations, recapitalization and the like).

President [Member]

Commitments And Contingencies [Line Items]

Stock Granted, Value, Share-based Compensation, Gross

$ 6,250

Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period | shares

1,500,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

100.00%

James Crawford

Commitments And Contingencies [Line Items]

Base Salary

$ 185,000

Consulting Agreement Monthly Fee Amount

$ 5,000

Constantine Potamianos

Commitments And Contingencies [Line Items]

Base Salary

150,000

Edward O'Donnell

Commitments And Contingencies [Line Items]

Base Salary

$ 165,000

Mr. Arena

Commitments And Contingencies [Line Items]

Base Salary

$ 275,000

Signing Bonus

$ 35,000

Other Consideration Value To Related Party

$ 54,892

Related Party Total Consideration Amount

479,892

Related Party Consideration Already Advanced

$ 250,909

Mr. Arena | PSUs

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares

3,000,000

Mr. Arena | Performance Target | PSUs

Commitments And Contingencies [Line Items]

Percentage Performance Targets Met

125.00%

Mr. Arena | Revenue goal | PSUs

Commitments And Contingencies [Line Items]

Percentage Psus Awards Granted

35.00%

Mr. Arena | Cash flow goal | PSUs

Commitments And Contingencies [Line Items]

Percentage Psus Awards Granted

35.00%

Mr. Arena | Discretionary Goal | PSUs

Commitments And Contingencies [Line Items]

Percentage Psus Awards Granted

30.00%

Mr. Arena | AIM Group, Inc [Member]

Commitments And Contingencies [Line Items]

Consulting Agreement Fee amount Net

$ 267,000

Consulting Agreement Fee Amount

425,000

Mr. Arena | Employee Stock Option [Member]

Commitments And Contingencies [Line Items]

Maximum Proceeds From Sale Of Stock Per Month

$ 500,000

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures | shares

500,000

Mr. Arena | Warrant [Member]

Commitments And Contingencies [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

250,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.40

Mr. Arena | Maximum [Member]

Commitments And Contingencies [Line Items]

Quarterly Bonus

$ 50,000

Mr. Arena | Maximum [Member] | Performance Target | PSUs

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares

3,000,000

Mr. Arena | Minimum [Member] | Performance Target | PSUs

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares

1,000,000

Percentage Performance Targets Met

75.00%

Dr. Carr Bettis [Member]

Commitments And Contingencies [Line Items]

Officers' Compensation

$ 175,000

Stock Granted, Value, Share-based Compensation, Gross

$ 750,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period | shares

2,000,000

Share Price Condition

(a) satisfaction of a share price condition described below; and (b) 100% achievement of the performance goals by the company and Dr. Bettis, as applicable. Subject to the share price condition, 50% of the target award will be earned by Dr. Bettis at the 85% achievement level, and he can earn up to 150% of the target award at the 125% achievement level. Vesting shall be determined based upon performance measures at the end of each calendar year of 2016 and 2017, with 50% of each target award and performance increase subject to vesting during each performance period.

Performance Objective Description

(a) Targeted cash contract bookings (as to 33.33%); (b) Targeted net operating cash flow (as to 33.33%); (c) Board defined operations goals (as to 33.33%) for a performance period. And, vesting shall only occur if the closing share price of the companys common stock on each of the 20 trading days before and including the end of a performance period is not less than $0.20 per share (as adjusted for stock splits, combinations, recapitalization and the like).

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

100.00%

Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares

500,000

500,000

Todd Bankofier [Member]

Commitments And Contingencies [Line Items]

Base Salary

$ 125,000

Share Price Condition

(a) satisfaction of a share price condition described below; and (b) 100% achievement of the performance goals by the company and Mr. Bankofier, as applicable. Subject to the share price condition, 50% of the target award will be earned by Mr. Bankofier at the 85% achievement level, and he can earn up to 150% of the target award at the 125% achievement level. Vesting shall be determined based upon performance measures at the end of each calendar year of 2016 and 2017, with 50% of each target award and performance increase subject to vesting during each performance period.

Performance Objective Description

(a) Targeted cash contract bookings (as to 33.33%); (b) Targeted net operating cash flow (as to 33.33%); (c) Board defined operations goals (as to 33.33%) for a performance period. And, vesting shall only occur if the closing share price of the companys common stock on each of the 20 trading days before and including the end of a performance period is not less than $0.20 per share (as adjusted for stock splits, combinations, recapitalization and the like).

Director [Member]

Commitments And Contingencies [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

180,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.25

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

7 years

Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares

602,620

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 72,917

Share Price | $ / shares

$ 0.121

Director [Member] | Restricted Stock Units (RSUs) [Member]

Commitments And Contingencies [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

7 years

Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares

650,000

STOCKHOLDERS_ EQUITY (Details)

STOCKHOLDERS’ EQUITY (Details) - USD ($)	Dec. 02, 2016	Jan. 15, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding
Outstanding at beginning of the period (in shares)		14,759,914	14,759,914
Granted (in shares)	1,391,188	6,500,000
Outstanding at the end of the period (in shares)			26,731,207	14,759,914
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Granted (in dollars per share)	$ 0.121	$ 0.038
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding
Outstanding at beginning of the period (in shares)		14,759,914	14,759,914	11,434,350
Granted (in shares)			12,508,877	8,278,880
Forfeited/Expired (in shares)			(1,537,584)	(4,953,316)
Outstanding at the end of the period (in shares)			25,731,207	14,759,914	11,434,350
Exercisable (in shares)			15,091,366	8,374,294	5,635,250
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at beginning of the period (in dollars per share)		$ 0.30	$ 0.30	$ 0.47
Granted (in dollars per share)			0.09	0.16
Forfeited/Expired (in dollars per share)			0.29	0
Outstanding at end of the period (in dollars per share)			$ 0.20	$ 0.30	$ 0.47
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures
Outstanding, Weighted Average Remaining Term			3 years 4 months 2 days	3 years 7 months 10 days	3 years 9 months 14 days
Granted Weighted Average Remaining Term			4 years 10 months 13 days
Share Based Compensation Arrangement by Share Based Payment Award Options, Intrinsic Value
Outstanding, Intrinsic Value (in dollars)			$ 1,161,244	$ 235,330	$ 460,941
Granted, Intrinsic Value of Exercisable Options			$ 0
Forfeited, Intrinsic Value of Exercisable Options			$ 0

STOCKHOLDERS_ EQUITY (Details 1

STOCKHOLDERS’ EQUITY (Details 1) - Warrant - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Number of warrants
Number of shares, beginning	43,246,858	16,527,989
Number of shares, granted	21,681,264	28,913,020
Number of shares, exercised		(109,855)
Number of shares, Forfeited	(1,495,081)	(2,084,296)
Number of shares, ending	63,433,041	43,246,858	16,527,989
Weighted average exercise price
Weighted average exercise price, beginning (in dollars per share)	$ 0.22	$ 0.46
Weighted average exercise price, granted (in dollars per share) | $ / shares	0.03	0.11
Weighted average exercise price, exercised (in dollars per share)		0.40
Weighted average exercise price, Forfeited (in dollars per share)	0.48	0.43
Weighted average exercise price, ending (in dollars per share)	$ 0.15	$ 0.22	$ 0.46
Weighted Average Remaining Term
Wtd Avg. Remaining Term	3 years 6 months 18 days	4 years 1 month 24 days	3 years 8 months 8 days
Weighted Average Remaining Term	4 years 10 months 13 days
Intrinsic Value
Outstanding, Intrinsic Value	$ 3,662,610	$ 1,167	$ 309,821

STOCKHOLDERS_ EQUITY (Details 2

STOCKHOLDERS’ EQUITY (Details 2) - Restricted Stock Units (RSUs) [Member] - shares	Dec. 07, 2016	Apr. 24, 2015	Dec. 31, 2016	Dec. 31, 2015
Number of shares, beginning			0	0
Granted	250,000	150,000	1,252,620	0
Number of shares, ending			1,252,620	0
Vested at December 31, 2016			0
Unvested restricted shares as of December 31, 2015				1,252,620

STOCKHOLDERS' EQUITY (Details T

STOCKHOLDERS' EQUITY (Details Textual) - USD ($)	Dec. 07, 2016	Dec. 02, 2016	Oct. 15, 2016	Jul. 15, 2016	May 12, 2016	Jan. 15, 2016	Jan. 04, 2016	Oct. 09, 2015	Jun. 02, 2015	May 01, 2015	Mar. 05, 2015	Mar. 05, 2015	Jan. 15, 2015	Dec. 31, 2016	Nov. 30, 2016	Oct. 31, 2016	Sep. 30, 2016	Aug. 31, 2016	Jul. 31, 2016	Jun. 15, 2016	May 31, 2016	Apr. 30, 2016	Apr. 15, 2016	Oct. 26, 2015	Apr. 24, 2015	Jan. 27, 2014	Nov. 30, 2015	Jun. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Nov. 08, 2015
Class of Stock [Line Items]
Common Stock, Shares, Issued														111,512,001															111,512,001	81,717,154
Common Stock, Shares, Outstanding														111,512,001															111,512,001	81,717,154
Proceeds from Issuance of Warrants																					$ 1,579,082								$ 0	$ 43,941
Stock Issued During Period, Shares, Issued for Services																	41,666	41,666	124,998			83,336
Stock Issued During Period Value Warrants Exercised								1,752,000													1,312,000
Shares, Issued										175,000
Conversion price (in dollars per share)										$ 0.1754
Stock Issued During Period, Value, Issued for Services																	$ 6,292	$ 6,208	$ 20,666			$ 14,292							$ 63,292	682,126
Stock Issued During Period, Shares, New Issues														41,666	41,666	41,666					11,714,285
Stock Issued During Period, Value, New Issues														$ 5,709	$ 4,917	$ 5,208
Proceeds From Units Sold To Accredited Investors													$ 325,000
Private Placement Cost For Units Sold To Accredited Investors										$ 1,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 0.10						$ 0.25							$ 0.25	$ 0.001					$ 0.10		$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		1,391,188				6,500,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$ 0.121				$ 0.038
Common Stock, Value, Issued														$ 1,115															$ 1,115	817
Share Price										$ 10				$ 0.14															$ 0.14
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period								5 years																			5 years		5 years
Proceeds from Issuance of Common Stock																													$ 2,129,082	325,000
Debt Instrument, Face Amount								$ 2,500,000																							$ 149,800
Cash														$ 1,409,418															$ 1,409,418	$ 1,687,257
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date		Dec. 2, 2021
Class of Warrant or Right, Outstanding														18,353,310								18,353,310							18,353,310
Preferred Stock, Par or Stated Value Per Share														$ 0.00001															$ 0.00001	$ 0.00001
Stock Issued During Period, Shares, Conversion of Convertible Securities																						12,834,800
Stock Issued During Period, Value, Conversion of Convertible Securities																						$ 1,025,000							$ 1,078,123
Interest Payable																						53,123
Payments of Stock Issuance Costs																					$ 63,292
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance														26,731,207															26,731,207	14,759,914
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value		$ 150,875
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights																				Vesting shall only occur if the closing share price of the Companys common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition)
Accrued Salaries, Current														$ 72,917															$ 72,917
Fair Value Assumptions, Weighted Average Volatility Rate																											102.00%		175.57%
Convertible Notes Payable [Member]
Class of Stock [Line Items]
Conversion price (in dollars per share)														$ 0.84															$ 0.84
Class of Warrant or Right, Outstanding														1,664,281															1,664,281
Debt Instrument, Convertible, If-converted Value in Excess of Principal																						$ 1,541,678							$ 1,541,678
Warrants and Rights Outstanding														$ 3,205,959															3,205,959
Share-based Compensation Award, Tranche One [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross												500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
Share-based Compensation Award, Tranche Two [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross												50,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		25.00%
Share-based Compensation Award, Tranche Three [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		25.00%
Employee Stock Option [Member]
Class of Stock [Line Items]
Allocated Share-based Compensation Expense																													864,024	$ 823,478
Deferred Compensation Liability, Current and Noncurrent														$ 482,153															$ 482,153	$ 406,157
Blackscholes Option Pricing Model [Member]
Class of Stock [Line Items]
Fair Value Assumptions, Risk Free Interest Rate																													1.24%
Share Price														$ 0.175															$ 0.175
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																													5 years
Fair Value Assumptions, Weighted Average Volatility Rate																													178.00%
Dividend Declared [Member]
Class of Stock [Line Items]
Shares Issued, Price Per Share										$ 12.50
Private Placement [Member]
Class of Stock [Line Items]
Exercise Price Of Units											$ 0.60
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													0.375
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross													812,500
Class of Warrant or Right, Outstanding													304,688
Consultant [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Warrants																												$ 43,941
Stock Issued During Period, Shares, Issued for Services																														2,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																														801,936
Proceeds from Issuance of Common Stock																														$ 109,855
Accredited investors [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues														3,928,573
Consultant One [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services																														236,626
Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period Value Warrants Exercised														440,000							1,312,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights														1,575,954															1,575,954
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.25							$ 0.25								$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																								41,667						208,332
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period																														124,998
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period								5 years
Share Based Compensation Arrangement By Share Based Payment Award Vesting Monthly																								41,667
Expected dividend yield (as a percent)																													0.00%
Allocated Share-based Compensation Expense																													$ 221,621	$ 510,436
Deferred Compensation Liability, Current and Noncurrent														$ 47,685															$ 47,685	$ 106,852
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum																													166.74%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum																													178.98%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum																													0.71%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum																													1.08%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate																													0.00%
Fair Value Assumptions, Weighted Average Volatility Rate								0.25%
Promissory Notes [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues								$ 2,500,000
Percentage Of Additional Principal Amount								50.00%
Paid In Kind Interest Percentage								10.00%
Debt Instrument, Face Amount								$ 3,750,000
Convertible Debt								$ 37,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number								25,000,000
Equity Securities Issued Percentage																													60.00%
Cash														$ 2,000,000															$ 2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price														$ 0.10															$ 0.10
June 2015 Issue One [Member]
Class of Stock [Line Items]
Exercise Price Of Units									$ 0.16
Stock Issued During Period, Shares, Issued for Services									1,250,000
Stock Issued During Period, Value, Issued for Services									$ 200,000
Units Sold To Accredited Investors Number Of Common Shares That Can Be Purchased Against Each Warrant									2,000,000
June 2015 Issue Two [Member]
Class of Stock [Line Items]
Exercise Price Of Units									$ 0.16
Stock Issued During Period, Shares, Issued for Services									800,000
Stock Issued During Period, Value, Issued for Services									$ 128,000
Units Sold To Accredited Investors Number Of Common Shares That Can Be Purchased Against Each Warrant									1,000,000
Performance Options [Member]
Class of Stock [Line Items]
Expected term						5 years
Expected volatility (as a percent)						162.00%
Risk-free interest rate (as a percent)						1.46%
Expected dividend yield (as a percent)						0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate						0.00%
Performance Options [Member] | Performance and Market Conditions [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						5,500,000
Non Performance Options [Member]
Class of Stock [Line Items]
Expected dividend yield (as a percent)																													0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate																													0.00%
Options Granted On April 2016 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																							49,715
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																							$ 0.179
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date																							Apr. 15, 2019
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value																							$ 6,250
Options Granted On May 2016 One [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.177
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					100,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date					May 12, 2021
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value					$ 16,694
Options Granted On May 2016 One [Member] | Share-based Compensation Award, Tranche One [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Options Granted On May 2016 One [Member] | Share-based Compensation Award, Tranche Two [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					4.17%
Options Granted On May 2016 Two [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					3,400,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 0.177
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date					May 12, 2021
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value					$ 559,603
Options Granted On May 2016 Two [Member] | Share-based Compensation Award, Tranche One [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Options Granted On May 2016 Two [Member] | Share-based Compensation Award, Tranche Two [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Options Granted On July 2016 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				56,375
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 0.156
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date				Jul. 15, 2019
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value				$ 6,250
Options Granted On June 2016 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																				300,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date																				Jun. 15, 2021
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value																				$ 40,723
Options Granted On June 2016 [Member] | Share-based Compensation Award, Tranche One [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage																				50.00%
Options Granted On October 2016 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			61,599
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$ 0.121
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date			Oct. 15, 2019
Share Based Compensation Arrangement by Share Based Payment Award, Options, Grants in Period Grant Date Fair Value			$ 5,209
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	7 years																								7 years
Maximum
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights														0.179															$ 0.179
Fair Value Assumptions, Risk Free Interest Rate																											1.75%		1.93%
Share Price														0.195													$ 0.058		$ 0.195
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																													4 years 11 months 19 days
Fair Value Assumptions, Weighted Average Volatility Rate																													178.00%
Maximum | Warrant [Member]
Class of Stock [Line Items]
Expected term																													2 years 6 months
Maximum | Non Performance Options [Member]
Class of Stock [Line Items]
Expected term																													3 years 6 months
Expected volatility (as a percent)																													176.77%
Risk-free interest rate (as a percent)																													1.73%
Minimum
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights														0.038															$ 0.038
Fair Value Assumptions, Risk Free Interest Rate																											1.14%		1.47%
Share Price														$ 0.150													$ 0.031		$ 0.150
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																													3 years 9 months 7 days
Fair Value Assumptions, Weighted Average Volatility Rate																													169.00%
Minimum | Warrant [Member]
Class of Stock [Line Items]
Expected term																													1 year 6 months
Minimum | Non Performance Options [Member]
Class of Stock [Line Items]
Expected term																													1 year 6 months
Expected volatility (as a percent)																													102.00%
Risk-free interest rate (as a percent)																													0.87%
Accredited investors
Class of Stock [Line Items]
Proceeds from Issuance of Warrants														$ 550,000
Stock Issued During Period Value Warrants Exercised														440,000
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.25															$ 0.25
Board of Directors Chairman [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage																													100.00%
Payments For Rent Half Hour											$ 12,500
Exeeded Fair Value Of Furniture											20,000
Share Based Compensation Arrangement By Share Based Payment Award Options Provisions											$ 500,000
Share Price Held In Escrow											50.00%
Professional Fees											$ 425,000
Effect on Future Earnings, Offset Amount											158,000
Effect on Future Earnings, Amount											267,000
Security Deposit											48,000	$ 48,000
Payments for Rent											6,250
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants											$ 1,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period											500,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross											500,000															500,000
Proceeds from Issuance Initial Public Offering											$ 3,000,000
Common Stock, Value, Issued											250,000	250,000
Escrow Deposit											$ 250,000	$ 250,000
Officer [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price							$ 0.038
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date							Jan. 4, 2019
Class Of Warrant Or Right Issued																													1,492,620
Officer [Member] | Maximum
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							500,000
Officer [Member] | Minimum
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							150,000
Director [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 72,917
Stock Issued During Period, Shares, New Issues																													1,607,137
Stock Issued During Period, Value, New Issues																													$ 225,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights														180,000															180,000
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.25															$ 0.25
Stock Issued During Period, Shares, Restricted Stock Award, Gross	602,620
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	7 years
Share Price	$ 0.121
Director [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross	650,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																													7 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 87,750
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Common Stock, Shares, Issued														160,000															160,000
Common Stock, Shares, Outstanding																														175,000
Redemption Price (in dollars per share)														$ 0.1754															$ 0.1754
Preferred Stock, Dividend Rate, Percentage										5.00%																			5.00%
Debt Instrument, Convertible, Beneficial Conversion Feature										$ 594,641
Cumulative Dividends																														$ 58,733
Preferred Stock, Par or Stated Value Per Share														$ 10															$ 10
Stock Issued During Period Shares Conversion Of Preferred Stock																					900,525
Conversion of Stock, Shares Converted																					15,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Net operating loss carry forwards	$ 7,558,530	$ 6,373,434
Less valuation allowance	(7,558,530)	(6,373,434)
Net deferred tax asset	$ 0	$ 0

INCOME TAXES (Details Textual)

INCOME TAXES (Details Textual) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Operating Loss Carryforwards	$ 22,230,971	$ 18,745,343

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual) - USD ($)	Mar. 10, 2017	Feb. 14, 2017	Jan. 03, 2017	Dec. 07, 2016	Dec. 02, 2016	Jan. 15, 2016	Oct. 09, 2015	Mar. 05, 2015	Feb. 28, 2017	Feb. 23, 2017	Jan. 31, 2017	Dec. 31, 2016	Nov. 30, 2016	Oct. 31, 2016	Sep. 30, 2016	Aug. 31, 2016	Jul. 31, 2016	May 31, 2016	Apr. 30, 2016	Oct. 26, 2015	Apr. 24, 2015	Mar. 31, 2017	Nov. 30, 2015	Dec. 31, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Common stock issued for services															41,666	41,666	124,998		83,336
Proceeds from exercise of warrants																		$ 1,579,082						$ 0	$ 43,941
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					1,391,188	6,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.10					$ 0.25						$ 0.25	$ 0.001				$ 0.10	$ 0.25
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 0.121	$ 0.038
Stock Issued During Period, Value, Issued for Services															$ 6,292	$ 6,208	$ 20,666		$ 14,292					$ 63,292	$ 682,126
Stock Issued During Period, Shares, New Issues												41,666	41,666	41,666				11,714,285
Stock Issued During Period Value Warrants Exercised							1,752,000											1,312,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period							5 years																5 years	5 years
Maximum [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.179												$ 0.179
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																								4 years 11 months 19 days
Minimum [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights												0.038												$ 0.038
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																								3 years 9 months 7 days
Share-based Compensation Award, Tranche One [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross								500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross								50,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					25.00%
Warrant [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																				41,667					208,332
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.25						$ 0.25						$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period																								21,681,264	28,913,020
Stock Issued During Period Value Warrants Exercised												440,000						1,312,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period							5 years
Restricted Stock Units (RSUs) [Member]
Subsequent Event [Line Items]
Vesting period				7 years																	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				250,000																	150,000			1,252,620	0
Subsequent Event
Subsequent Event [Line Items]
Common stock issued for services									41,666		41,666											41,666
Proceeds from exercise of warrants											$ 50,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	100,000		100,000
Vesting period	5 years		5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.25
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.145		$ 0.159
Stock Issued During Period, Value, Issued for Services									$ 5,333		$ 6,625											$ 5,917
Stock Issued During Period, Shares, New Issues											357,143
Stock Issued During Period Value Warrants Exercised											40,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross										402,297
Stock Issued During Period, Value, Restricted Stock Award, Gross										$ 58,333
Subsequent Event | Share-based Compensation Award, Tranche One [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%		50.00%
Subsequent Event | Share-based Compensation Award, Tranche Two [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%		50.00%
Subsequent Event | Warrant [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.12
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		250,000
Subsequent Event | Warrant [Member] | Maximum [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		5 years
Subsequent Event | Warrant [Member] | Minimum [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		3 years
Subsequent Event | Restricted Stock Units (RSUs) [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period										7 years